Abstract
Myelodysplastic syndromes (MDS), are a heterogenic group of hematopoietic disorders caused by changes in pluripotent cells, common in the elderly, and a high rate of progression to acute myeloid leukemias (AML). These syndromes are characterized by ineffective hematopoiesis resulting in present dysplasia, impaired differentiation and peripheral blood cytopenias and result from multiple ch…